MedTrace Logo

Study Evaluating Occupational Exposure to Antineoplastic Drugs

NCT06343103 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-04-02

No results posted yet for this study

Summary

The multicenter study involves comparing two groups (an exposed group and a control group). The exposed group is selected from workers who perform their activities in drug handling areas (DH) or units for antineoplastic preparation (UFA), while the control group involves the voluntary participation of non-exposed workers (administrative staff).

The control group is selected based on the characteristics of the exposed group to ensure a homogeneous sample in terms of size and characteristics.

Conditions

  • Cytotoxicity

Interventions

OTHER

Workers exposed

Workers exposed to cytotoxic agents

OTHER

Workers not exposed

Workers not exposed to cytotoxic agents

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Emanuela Omodeo Salè · European Institute of Oncology

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-02
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06343103 on ClinicalTrials.gov